Categories: aggregated

What is AEF-0117?- Big Pharma’s New Drug to Get You Off of Cannabis and Back on Prescription Drugs As Soon As Possible

In a bid to capitalize on the increasing prevalence of cannabis consumption in the US, pharmaceutical companies have introduced a new pill that claims to combat marijuana addiction. The experimental drug, AEF-0117, has shown promise in a small trial by reducing the addictive impact of THC, the primary psychoactive compound in cannabis. While the study published in the journal Nature Medicine may appear encouraging at first glance, a closer examination raises several concerns about the motives behind such pharmaceutical interventions.

Jason

Share
Published by
Jason

Recent Posts

5 Cannabis Christmas Recipes to Try This Holiday Season at Home or the Office Party!

To help make your holidaze more "dazey," I've crafted five festive recipes that combine seasonal…

10 hours ago

The Grinch Stole SAFE Banking from the Cannabis Industry This Christmas, Yet Again!

As of December 2024, it has become official: the current Congress will not provide any…

1 day ago

What Federally Illegal Drug Has Created Almost $10 Billion in Sales Tax Revenue for States in the Last 40 Months?

In a significant development for the burgeoning cannabis industry, the U.S. Census Bureau has reported…

3 days ago

Are MSOs Just Big Pharma on Steriods? – Anti-Pot Florida Governor Says Large Cannabis Companies are Just Drug Companies Part 2

The ongoing debate over cannabis legalization in Florida reflects broader national trends regarding marijuana policy.…

4 days ago

2024’s cannabis award-winners and where to buy them

Shop the winners near you. The post 2024’s cannabis award-winners and where to buy them…

5 days ago